Porton USA LLC

Porton Pharma Solutions, a global company with R&D and GMP-compliant manufacturing facilities across the US, EU and China, provides customer-centric innovative and reliable CDMO solutions for Small Molecules, Tides, Biologics and Conjugates (ADCs, AOCs, PDCs, RDCs, etc.), and Advanced Therapy Medicinal Products from pre-clinical to commercial stages

As a subsidiary of Porton Pharma Solutions, a globally recognized CDMO, Porton Biologics and Conjugates CDMO Platform offers comprehensive, one-stop drug development and manufacturing services for biologics and conjugates, including ADCs, AOCs, PDCs, RDCs and more.

With four major R&D platforms including peptides, oligonucleotides, high-performance liquid chromatography, and Tides analysis, the Porton Tides CDMO Services Platform is committed to providing integrated CMC solutions for global customers, covering all types of new drugs from pre-clinical to commercial.

It is the first CDMO-type company in the pharmaceutical industry in Slovenia, dedicated to providing comprehensive services to customers, encompassing synthesis route development, process familiarization, analytical method development and validation, and process scale-up.

Porton has a professional technology platform and an experienced team to provide global clients with CMC solutions for radiopharmaceutical precursors and cold drugs. We are committed to becoming the leading RDC CDMO company in China.

A Customer-centric, Innovativeand Reliable CDMO with Global Solutions

 Learn how Porton Pharma Solutions Ltd.'s advanced CMC strategies improve selectivity, minimize toxicity, and overcome drug resistance.  Understand BsADC design innovations, Discover new conjugation methods, Solve challenges in CMC development, Improve clinical outcomes

With advances in computational materials science and process simulation, computational applications are becoming an integral part of the drug development and manufacturing workflow.1,2These methods facilitate easier navigation through the complex multidimensional space of pharmaceutical process development tasks

Co-processing: Co-Precipitation Technology (CPT) for the Enhancement of Flowability and Bulk Density


Formulating compressed tablets is one of the most widely used oral solid form dosages. However, a vital first step is choosing a suitable manufacturing approach and the right excipients to support the desired therapeutic effect.